Since the FDA decided to reschedule all hydrocodone products to C-II from C-III, the regulatory compliance burden on pharmacies to track these medications is set to substantially increase overnight. Is your pharmacy ready for the change? RxSafe's industry-leading analytics and reporting services can help save you time and money. Contact us to learn more about how our pharmacy automation can help your pharmacy stay ahead of the curve.
